These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28725321)

  • 1. Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study.
    Aoki K; Nagakura M; Taguri M; Kamiyama H; Masumura M; Furuie T; Oka M; Kamiko K; Nakajima S; Akema N; Terauchi Y
    J Clin Med Res; 2017 Aug; 9(8):719-724. PubMed ID: 28725321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs. loose-dose combination of oral anti-diabetes drugs.
    Lokhandwala T; Smith N; Sternhufvud C; Sörstadius E; Lee WC; Mukherjee J
    J Med Econ; 2016; 19(3):203-12. PubMed ID: 26473990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.
    Perez A; Zhao Z; Jacks R; Spanheimer R
    Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin A1c outcomes and health care resource use in type 2 diabetes mellitus patients treated with combination oral antidiabetic drugs through step therapy and loose-dose and fixed-dose combinations.
    Williams SA; Buysman EK; Hulbert EM; Bergeson JG; Zhang B; Graham J
    Manag Care; 2012 Jul; 21(7):40-8. PubMed ID: 22876522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.
    Kim HS; Kim DM; Cha BS; Park TS; Kim KA; Kim DL; Chung CH; Park JH; Jang HC; Choi DS
    J Diabetes Investig; 2014 Nov; 5(6):701-8. PubMed ID: 25422771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update.
    Moses RG
    Diabetes Metab Syndr Obes; 2010 May; 3():145-54. PubMed ID: 21437084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fixed-dose combination].
    Nagai Y
    Nihon Rinsho; 2015 Mar; 73(3):465-9. PubMed ID: 25812374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients.
    Czarnecka D; Koch EM; Gottwald-Hostalek U
    Curr Med Res Opin; 2015 May; 31(5):875-81. PubMed ID: 25753136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing pattern of anti-diabetic drugs and adherence to the American Diabetes Association's (ADA) 2021 treatment guidelines among patients of type 2 diabetes mellitus: A cross-sectional study.
    Tiwari K; Bisht M; Kant R; Handu SS
    J Family Med Prim Care; 2022 Oct; 11(10):6159-6164. PubMed ID: 36618206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination.
    Panagoulias GS; Doupis J
    Patient Prefer Adherence; 2014; 8():227-36. PubMed ID: 24627627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
    Barner JC
    Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects.
    Rhee SJ; Lee S; Yoon SH; Cho JY; Jang IJ; Yu KS
    Drug Des Devel Ther; 2016; 10():1411-8. PubMed ID: 27110098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Effect of Alogliptin on Glycemic Control in Japanese Patients With Type 2 Diabetes: A 3.5-Year Observational Study.
    Takebayashi K; Suzuki T; Naruse R; Hara K; Suetsugu M; Tsuchiya T; Inukai T
    J Clin Med Res; 2017 Sep; 9(9):802-808. PubMed ID: 28811859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
    BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic outcomes associated with amlodipine/renin-angiotensin system blocker combinations.
    Ferrario CM; Panjabi S; Buzinec P; Swindle JP
    Ther Adv Cardiovasc Dis; 2013 Feb; 7(1):27-39. PubMed ID: 23328188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Hypertensive Patients with a Fixed-Dose Combination of Bisoprolol and Amlodipine: Results of a Cohort study with More Than 10,000 Patients.
    Hostalek U; Czarnecka D; Koch EM
    Cardiol Ther; 2015 Dec; 4(2):179-90. PubMed ID: 26253777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis.
    Han S; Iglay K; Davies MJ; Zhang Q; Radican L
    Curr Med Res Opin; 2012 Jun; 28(6):969-77. PubMed ID: 22494018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes.
    Lingvay I; Beetz N; Sennewald R; Schuler-Metz A; Bertulis J; Loley C; Lang B; Lippert C; Lee J; Manning LS; Terada D
    Postgrad Med; 2020 May; 132(4):337-345. PubMed ID: 32366156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
    Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.